Skip to main content
. 2021 Sep 30;39(34):3822–3828. doi: 10.1200/JCO.21.01213

FIG 1.

FIG 1.

Genomic alterations and drug targets across 45 SPUs: (A) genes identified with targetable mutations across the study cohort, (B) alteration mechanisms among targeted genes, and (C) SPU drug targets on the basis of corresponding genomic alterations. SNV, single-nucleotide variation; SPU, single patient use.